Physician
VMD Primary Providers Central Kentucky
VMD Primary Providers Central Kentucky was paid $4.37M by Medicaid between Jan 2020 and Dec 2024, across 146 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoVMD PRIMARY PROVIDERS CENTRAL KENTUCKY
MURRAY, KY 42071
MURRAY, KY 42071
33aNPI1831674654assigned 09/27/2018
33bProvider typeFamily Medicine Physician
28Total paid$4.37M
24GClaims503,021
24DCodes billed146
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Kentucky
Rank by total paid#18 of 352
Median peer was paid$90K
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RAGER, REBECCA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 30,194 | $520K | |
| 2021 | 89,816 | $916K | |
| 2022 | 140,231 | $1.11M | |
| 2023 | 173,485 | $1.14M | |
| 2024incomplete | 69,295 | $685K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 35,869 | 29,935 | $1.44M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 35,856 | 29,009 | $1.04M |
| 87428 | 8.5% | 7,072 | 6,155 | $372K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.7% | 3,283 | 3,008 | $160K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.8% | 3,802 | 3,462 | $124K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.5% | 3,495 | 2,989 | $111K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.5% | 4,380 | 3,987 | $110K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.4% | 1,579 | 1,410 | $106K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.2% | 1,386 | 1,286 | $98K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.8% | 1,376 | 1,143 | $78K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 13,846 | 12,052 | $75K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.7% | 913 | 858 | $75K |
134 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.5% | 3,199 | $64K |
| 80061 | Lipid panel | <1% | 4,578 | $40K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 632 | $35K |
| 87430 | <1% | 2,578 | $35K | |
| 90461 | <1% | 1,165 | $31K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 3,110 | $30K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,490 | $27K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,659 | $26K |
| 80053 | Comprehensive metabolic panel | <1% | 3,060 | $18K |
| 90670 | <1% | 388 | $18K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 17,561 | $17K |
| 80076 | <1% | 2,714 | $16K | |
| 81001 | <1% | 6,874 | $16K | |
| 90671 | <1% | 171 | $15K | |
| 87634 | <1% | 253 | $15K | |
| 92551 | <1% | 1,192 | $13K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 496 | $12K |
| 99441 | <1% | 502 | $11K | |
| 99442 | <1% | 299 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,926 | $10K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 521 | $10K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 15 | $9K |
| 83655 | <1% | 749 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 796 | $8K |
| 96127 | <1% | 2,087 | $7K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 109 | $7K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 251 | $5K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 194 | $5K |
| 90619 | <1% | 106 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 512 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 242 | $5K |
| 87807 | <1% | 331 | $4K | |
| 99223 | Prolong inpt eval add15 m | <1% | 86 | $3K |
| 97802 | <1% | 524 | $3K | |
| 90698 | <1% | 280 | $3K | |
| 90686 | <1% | 289 | $3K | |
| 99349 | <1% | 189 | $3K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 31 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 30 | $2K |
| 96160 | <1% | 626 | $2K | |
| 99188 | <1% | 148 | $2K | |
| 90710 | <1% | 46 | $2K | |
| 59430 | <1% | 31 | $2K | |
| 93000 | <1% | 78 | $2K | |
| 90680 | <1% | 52 | $1K | |
| 84439 | <1% | 226 | $1K | |
| 99384 | <1% | 18 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 115 | $1K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 88 | $1K |
| 90633 | <1% | 208 | $1K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,298 | $1K |
| 99383 | <1% | 12 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 73 | $1K |
| 90715 | <1% | 145 | $1K | |
| 90734 | <1% | 182 | $948.75 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 43 | $833.35 |
| 90682 | <1% | 25 | $790.06 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 67 | $753.84 |
| 90696 | <1% | 46 | $722.92 | |
| 90697 | <1% | 113 | $649.54 | |
| 76830 | Ultrasound, transvaginal | <1% | 16 | $623.45 |
| 99219 | <1% | 14 | $602.43 | |
| 0071A | <1% | 16 | $569.60 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 242 | $568.76 |
| 99217 | <1% | 18 | $486.31 | |
| 94760 | <1% | 973 | $452.30 | |
| 99350 | Prolong home eval add 15m | <1% | 25 | $436.79 |
| 90744 | <1% | 158 | $360.57 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 20 | $300.01 |
| 90677 | <1% | 30 | $283.72 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 55 | $233.53 |
| 90651 | <1% | 42 | $216.36 | |
| 90681 | <1% | 63 | $203.70 | |
| 84703 | <1% | 31 | $188.45 | |
| 96161 | <1% | 71 | $158.73 | |
| 85651 | <1% | 42 | $157.56 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 17 | $148.00 |
| 36416 | <1% | 648 | $144.48 | |
| 82950 | <1% | 29 | $114.50 | |
| 81003 | <1% | 133 | $110.20 | |
| 87210 | <1% | 22 | $58.20 | |
| 99072 | <1% | 2,737 | $50.00 | |
| 99305 | <1% | 16 | $48.80 | |
| 3074F | <1% | 28,864 | $43.57 | |
| 1125F | <1% | 15,671 | $39.56 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 137 | $37.58 |
| 3078F | <1% | 25,184 | $36.34 | |
| 1126F | <1% | 12,846 | $30.56 | |
| 3008F | <1% | 47,971 | $29.22 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 15 | $27.30 |
| 3079F | <1% | 10,476 | $24.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 73 | $14.12 |
| 3075F | <1% | 4,790 | $11.71 | |
| 3077F | <1% | 880 | $2.46 | |
| 1160F | <1% | 49,569 | $1.86 | |
| 1159F | <1% | 45,876 | $1.80 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 651 | $1.16 |
| 3080F | <1% | 355 | $1.00 | |
| 3044F | <1% | 119 | $0.13 | |
| 99491 | Ccm add 20min | <1% | 14 | $0.12 |
| 90672 | <1% | 104 | $0.04 | |
| 99499 | <1% | 625 | $0.04 | |
| 1034F | <1% | 9,349 | $0.04 | |
| 90685 | <1% | 46 | $0.02 | |
| 90647 | <1% | 16 | $0.02 | |
| 1036F | <1% | 28,771 | $0.01 | |
| 3725F | 0% | 16,079 | $0.00 | |
| 0521F | 0% | 69 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 57 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 957 | $0.00 |
| 2028F | 0% | 48 | $0.00 | |
| 3288F | 0% | 37 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 21 | $0.00 |
| 99497 | 0% | 21 | $0.00 | |
| 1124F | 0% | 56 | $0.00 | |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 0% | 25 | $0.00 |
| 888888 | 0% | 56 | $0.00 | |
| 1090F | 0% | 22 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 15 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 12,052 | $0.00 |
| 1000F | 0% | 844 | $0.00 | |
| 1035F | 0% | 137 | $0.00 | |
| 99000 | 0% | 1,999 | $0.00 | |
| 3048F | 0% | 636 | $0.00 | |
| 1170F | 0% | 77 | $0.00 | |
| 3049F | 0% | 17 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 20 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 58 | $0.00 |
| 0503F | 0% | 96 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 15 | $0.00 |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 0% | 28 | $0.00 |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 41 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 15 | $0.00 |
| 1101F | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAGER, REBECCA (DIRECTOR REVENUE CYCLE)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.